Skip to content

Clinical trials

Systemic Inflammatory Response Syndrome trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Systemic Inflammatory Response Syndrome Country / region: Spain Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20121
20162
20171
20181
20201
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Althaia Xarxa Assistencial Universitària de Manresa1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Hospital General Universitario Gregorio Marañon1
Hospital Universitari de Bellvitge1
Hospital Universitario Getafe1
Hospital Universitario La Paz1
Maimónides Biomedical Research Institute of Córdoba1
Mundipharma Research Limited1
PEACHES BIOTECH1
Spanish Network for Research in Infectious Diseases1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Systemic Inflammatory Response Syndrome11
Sepsis5
Pathologic Processes3
COVID-192
Candidemia2
Candidiasis2
Candidiasis, Invasive2
Fungemia2
Infections2
Inflammation2

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.